Protagonist Therapeutics

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$4,167
$254,953
$60,000
$0
Gross Profit
3,275
254,133
59,168
-827
EBITDA
-37,901
207,129
23,881
-38,326
EBIT
-38,793
206,309
23,049
-39,153
Net Income
-30,616
207,340
27,335
-34,105
Net Change In Cash
4,167
254,953
60,000
0
Free Cash Flow
268,594
-27,671
16,941
-27,015
Cash
355,643
172,568
186,727
230,527
Basic Shares
61,305
63,595
61,796
59,182

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$60,000
$26,581
$27,357
$28,628
Gross Profit
56,688
26,581
24,582
28,628
EBITDA
-90,340
-128,004
-125,551
-63,662
EBIT
-93,652
-131,373
-128,326
-64,451
Net Income
-78,955
-123,413
-122,627
-66,150
Net Change In Cash
60,000
26,581
27,357
28,628
Cost of Revenue
2,169
6,198
84,177
Free Cash Flow
-70,845
-108,932
-108,966
-72,955
Cash
186,727
125,744
123,665
117,358
Basic Shares
56,763
49,042
46,322
34,396

Earnings Calls

Quarter EPS
2024-06-30
-$0.50
2024-03-31
$3.26
2023-12-31
$0.44
2023-09-30
-$0.58